Acute barbiturate poisoning is associated with symptoms such as drowsiness, confusion, coma, respiratory depression, hypotension, and shock.
Talbutal, also called 5-allyl-5-sec-butylbarbituric acid, is a barbiturate with a short to intermediate duration of action. Talbutal is a schedule III drug in the U.S.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Talbutal may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Talbutal. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Talbutal. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Talbutal. |
| Hydrocodone | Talbutal may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Talbutal. |
| Magnesium sulfate | The therapeutic efficacy of Talbutal can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Talbutal may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Talbutal may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Talbutal. |
| Mirtazapine | Talbutal may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Talbutal. |
| Orphenadrine | Talbutal may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Talbutal may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Talbutal. |
| Pramipexole | Talbutal may increase the sedative activities of Pramipexole. |
| Ropinirole | Talbutal may increase the sedative activities of Ropinirole. |
| Rotigotine | Talbutal may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Talbutal. |
| Suvorexant | Talbutal may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Talbutal. |
| Thalidomide | Talbutal may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Talbutal may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Secretin porcine | The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Talbutal. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Talbutal. |
| Sodium oxybate | Talbutal may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Botulinum toxin type A | The risk or severity of adverse effects can be increased when Talbutal is combined with Botulinum toxin type A. |
| Botulinum toxin type B | The risk or severity of adverse effects can be increased when Talbutal is combined with Botulinum toxin type B. |
| Ethanol | Talbutal may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Talbutal may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Talbutal. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Talbutal is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Talbutal is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Talbutal is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Talbutal is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Talbutal is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Talbutal is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Talbutal is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Talbutal is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Talbutal is combined with Escitalopram. |
| Zimelidine | The risk or severity of adverse effects can be increased when Talbutal is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Talbutal is combined with Dapoxetine. |
| Milnacipran | The risk or severity of adverse effects can be increased when Talbutal is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Talbutal is combined with Desvenlafaxine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Talbutal is combined with Seproxetine. |
| Indalpine | The risk or severity of adverse effects can be increased when Talbutal is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Talbutal is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Talbutal is combined with Alaproclate. |
| Naltrexone | The risk or severity of adverse effects can be increased when Talbutal is combined with Naltrexone. |
| Bezitramide | The risk or severity of adverse effects can be increased when Talbutal is combined with Bezitramide. |
| Morphine | The risk or severity of adverse effects can be increased when Talbutal is combined with Morphine. |
| Codeine | The risk or severity of adverse effects can be increased when Talbutal is combined with Codeine. |
| Hydromorphone | The risk or severity of adverse effects can be increased when Talbutal is combined with Hydromorphone. |
| Meperidine | The risk or severity of adverse effects can be increased when Talbutal is combined with Meperidine. |
| Oxycodone | The risk or severity of adverse effects can be increased when Talbutal is combined with Oxycodone. |
| Butorphanol | The risk or severity of adverse effects can be increased when Talbutal is combined with Butorphanol. |
| Dextropropoxyphene | The risk or severity of adverse effects can be increased when Talbutal is combined with Dextropropoxyphene. |
| Pentazocine | The risk or severity of adverse effects can be increased when Talbutal is combined with Pentazocine. |
| Sufentanil | The risk or severity of adverse effects can be increased when Talbutal is combined with Sufentanil. |
| Alfentanil | The risk or severity of adverse effects can be increased when Talbutal is combined with Alfentanil. |
| Fentanyl | The risk or severity of adverse effects can be increased when Talbutal is combined with Fentanyl. |
| Nalbuphine | The risk or severity of adverse effects can be increased when Talbutal is combined with Nalbuphine. |
| Levorphanol | The risk or severity of adverse effects can be increased when Talbutal is combined with Levorphanol. |
| Remifentanil | The risk or severity of adverse effects can be increased when Talbutal is combined with Remifentanil. |
| Diphenoxylate | The risk or severity of adverse effects can be increased when Talbutal is combined with Diphenoxylate. |
| Oxymorphone | The risk or severity of adverse effects can be increased when Talbutal is combined with Oxymorphone. |
| Dezocine | The risk or severity of adverse effects can be increased when Talbutal is combined with Dezocine. |
| Levacetylmethadol | The risk or severity of adverse effects can be increased when Talbutal is combined with Levacetylmethadol. |
| Methadyl acetate | The risk or severity of adverse effects can be increased when Talbutal is combined with Methadyl acetate. |
| Dihydroetorphine | The risk or severity of adverse effects can be increased when Talbutal is combined with Dihydroetorphine. |
| Diamorphine | The risk or severity of adverse effects can be increased when Talbutal is combined with Diamorphine. |
| Ethylmorphine | The risk or severity of adverse effects can be increased when Talbutal is combined with Ethylmorphine. |
| Etorphine | The risk or severity of adverse effects can be increased when Talbutal is combined with Etorphine. |
| Dextromoramide | The risk or severity of adverse effects can be increased when Talbutal is combined with Dextromoramide. |
| Desomorphine | The risk or severity of adverse effects can be increased when Talbutal is combined with Desomorphine. |
| Carfentanil | The risk or severity of adverse effects can be increased when Talbutal is combined with Carfentanil. |
| Dihydrocodeine | The risk or severity of adverse effects can be increased when Talbutal is combined with Dihydrocodeine. |
| Alphacetylmethadol | The risk or severity of adverse effects can be increased when Talbutal is combined with Alphacetylmethadol. |
| Dihydromorphine | The risk or severity of adverse effects can be increased when Talbutal is combined with Dihydromorphine. |
| Ketobemidone | The risk or severity of adverse effects can be increased when Talbutal is combined with Ketobemidone. |
| DPDPE | The risk or severity of adverse effects can be increased when Talbutal is combined with DPDPE. |
| Lofentanil | The risk or severity of adverse effects can be increased when Talbutal is combined with Lofentanil. |
| Opium | The risk or severity of adverse effects can be increased when Talbutal is combined with Opium. |
| Normethadone | The risk or severity of adverse effects can be increased when Talbutal is combined with Normethadone. |
| Piritramide | The risk or severity of adverse effects can be increased when Talbutal is combined with Piritramide. |
| Alphaprodine | The risk or severity of adverse effects can be increased when Talbutal is combined with Alphaprodine. |
| Nicomorphine | The risk or severity of adverse effects can be increased when Talbutal is combined with Nicomorphine. |
| Meptazinol | The risk or severity of adverse effects can be increased when Talbutal is combined with Meptazinol. |
| Phenoperidine | The risk or severity of adverse effects can be increased when Talbutal is combined with Phenoperidine. |
| Phenazocine | The risk or severity of adverse effects can be increased when Talbutal is combined with Phenazocine. |
| Tilidine | The risk or severity of adverse effects can be increased when Talbutal is combined with Tilidine. |
| Carfentanil, C-11 | The risk or severity of adverse effects can be increased when Talbutal is combined with Carfentanil, C-11. |
| Benzhydrocodone | The risk or severity of adverse effects can be increased when Talbutal is combined with Benzhydrocodone. |
| Naloxegol | The risk or severity of adverse effects can be increased when Talbutal is combined with Naloxegol. |
| Mecamylamine | The risk or severity of adverse effects can be increased when Talbutal is combined with Mecamylamine. |
| Tropicamide | The risk or severity of adverse effects can be increased when Talbutal is combined with Tropicamide. |
| Amantadine | The risk or severity of adverse effects can be increased when Talbutal is combined with Amantadine. |
| Cyclopentolate | The risk or severity of adverse effects can be increased when Talbutal is combined with Cyclopentolate. |
| Pentolinium | The risk or severity of adverse effects can be increased when Talbutal is combined with Pentolinium. |
| Trimethaphan | The risk or severity of adverse effects can be increased when Talbutal is combined with Trimethaphan. |